–
SURABAYA | duta.co – Daewoong Pharmaceutical (CEO Seung-ho Jeon) announced that the company has published a video lecture on ‘the importance of medication adherence for hypertensive and dyslipidemic patients’ through’ Sharedoc, ”a platform devoted to sharing medical knowledge from Daewoong Pharmaceutical.
This online lecture discusses the comparison of drug use adherence between hypertensive and dyslipidemic patients in Indonesia and Korea, how to increase medication adherence through the application of combination treatment, the benefits of combination treatment, and the application of cross-series fixed dose combination (FDC) in hypertensive and dyslipidemic patients.
This lecture was delivered by Dr. dr. Tri Juli Edi Tarigan, SpPD., KEMD, a specialist in internal medicine at Dr. Cipto Mangunkusumo, he is also a Doctor or Professor of Internal Medicine at the Faculty of Medicine, University of Indonesia.
Sharedoc was launched by Daewoong Pharmaceutical in September 2020 and is a global platform for sharing medical knowledge where medical staff around the world can learn and share useful information for practical and academic research via the website (www.dwsharedoc.com).
Through Sharedoc, users can access a variety of quality content related to Daewoong Pharmaceutical’s product characteristics, key clinical results, prescription notes, and more to improve their understanding of medicines and get useful reference information in the health sector.
Eka Bobby Saputra, Online Marketing Manager for Sharedoc Indonesia, who is actively serving at Daewoong Pharmaceutical, said, “Sharedoc provides an opportunity to expand the network of health experts through non-face-to-face activities, in addition to the latest drug information and industry trends can also be shared through Sharedoc”. He added, “This lecture is prepared to respond to the high interest of the domestic health care sector in the treatment of hypertension and dyslipidemia, which are cardiovascular diseases with the highest incidence rate in Indonesia. This lecture is expected to contribute in improving the quality of life for patients with hypertension and dyslipidemia ”.
Meanwhile, Daewoong Pharmaceutical has developed a combination treatment to treat hypertension and dyslipidemia at the same time as the company’s research and technology launched in Korea in 2014. The treatment of hypertension and dyslipidemia from Daewoong Pharmaceutical is a combination drug of olmesartan and rosuvastatin. optimal drug absorption rate in the body with a double-layered tablet formulation that regulates the release rate, the capabilities of the technological devices that allow this to happen are patented. The clinical trial results of this drug have just been published in the Academic Journal of Therapeutics, a globally renowned international SCI academic journal, so that the value of Daewoong Pharmaceutical’s hypertension and dyslipidemia treatment will be more recognized worldwide.
The video lecture is about 30 minutes long and is equipped with English subtitles. After signing up for Sharedoc, users can access content for free. New content will be released every week. Apart from that, Sharedoc allows deeper discussion because this platform is designed not only to listen to lectures, but also to ask questions and receive answers in the comments section.
For more information about Sharedoc, please visit the Sharedoc website and Instagram page (dwsharedoc). Information about lecture schedules and upload schedules will be shared on Instagram. Imm
–
